Adaptive Biotechnologies Corp’s Market Journey: Closing Weak at 3.11, Down -3.42

Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.

The closing price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) was $3.11 for the day, down -3.42% from the previous closing price of $3.22. In other words, the price has decreased by -$3.42 from its previous closing price. On the day, 1.11 million shares were traded. ADPT stock price reached its highest trading level at $3.28 during the session, while it also had its lowest trading level at $3.1.


Our analysis of ADPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.50 and its Current Ratio is at 4.66. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.71.

On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.

Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’24 when ROBINS CHAD M sold 48,673 shares for $3.43 per share. The transaction valued at 167,007 led to the insider holds 2,576,701 shares of the business.

RUBINSTEIN JULIE sold 39,070 shares of ADPT for $135,764 on Mar 05 ’24. The President now owns 472,754 shares after completing the transaction at $3.47 per share. On Mar 05 ’24, another insider, BENZENO SHARON, who serves as the Chief Commercial Ofc Imm Med of the company, sold 29,390 shares for $3.44 each. As a result, the insider received 100,994 and left with 327,415 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 458314464 and an Enterprise Value of 334146976. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.69 while its Price-to-Book (P/B) ratio in mrq is 1.46. Its current Enterprise Value per Revenue stands at 1.962 whereas that against EBITDA is -1.863.

Stock Price History:

Over the past 52 weeks, ADPT has reached a high of $9.08, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is -0.43%, while the 200-Day Moving Average is calculated to be -32.40%.

Shares Statistics:

ADPT traded an average of 1.73M shares per day over the past three months and 1489070 shares per day over the past ten days. A total of 145.08M shares are outstanding, with a floating share count of 140.68M. Insiders hold about 4.54% of the company’s shares, while institutions hold 92.20% stake in the company. Shares short for ADPT as of 1713139200 were 10005472 with a Short Ratio of 5.78, compared to 1710460800 on 8457164. Therefore, it implies a Short% of Shares Outstanding of 10005472 and a Short% of Float of 8.72.

Most Popular

[the_ad id="945"]